Characterization of PI3KCA and BRAF mutations in gastric adenocarcinoma: An approach to a personalized targeted therapy for Moroccan HER2 overexpressed patients-Reference-Cited by-同舟云学术

Characterization of PI3KCA and BRAF mutations in gastric adenocarcinoma: An approach to a personalized targeted therapy for Moroccan HER2 overexpressed patients

Published:2018-12 Issue:4 Volume:19 Page:155-158
ISSN:1687-1979
Container-title:Arab Journal of Gastroenterology
language:en
Short-container-title:Arab Journal of Gastroenterology

Author:

Joutei Hanaa Amrani Hassani,Marchoudi Nabila,Mahfoud Wafaa,Sadaoui Ilham,Fechtali Taoufiq,Benomar Hakima

Publisher

Elsevier BV

Subject

Gastroenterology

Reference37 articles.

1. HER2 testing in gastric cancer;Pecciarini;Adv Anat Pathol,2011

2. Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes: a systematic review;Albarello;Int J Cancer,2012

3. Recent advances in the HER2 targeted therapy of gastric cancer;Matsuoka;World J Clin Cases 16,2015

4. HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies;Gajria;Expert Rev Anticancer Ther,2011

5. PI3KCA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas;Black;Br J Cancer,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer;CHINESE J CANCER RES;2024

2. Gastric cancer in the Arab World: a systematic review;Eastern Mediterranean Health Journal;2022-07-30

3. Genetic variants association with cancers in African-based populations: A systematic review;Cancer Epidemiology;2020-08